side effects of aod9604 AOD-9604 vs MOTS-c: Side-Effect Profile Head-to-Head Peptide AOD 9604 Therapy

There is no receptor to desensitise on a fast clock, and no acute spike to time around a meal

Third-party testing provides independent verification of compound quality that researchers need to maintain experimental validity

Payment Due to the nature of research peptides and the high-risk category assigned by payment processors, credit card companies do not generally support merchants in this field

5-Amino-1-methylquinolinium iodide, NNMTi, CID 66522933

Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent